彻底改变癌症药物开发:利用篮子试验的潜力
Vivek Subbiah1, Howard A Burris1, Razelle Kurzrock2,3
1Sarah Cannon Research Institute, Nashville, Tennessee, USA.
Cancer
|November 7, 2023
概括
篮子试验有效地测试了针对各种癌症类型的向癌症疗法,基于分子变化,而不是组织学. 这些创新的临床试验正在彻底改变个性化癌症治疗,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 临床试验设计 临床试验设计
- 基因组学就是基因组学.
背景情况:
- 癌症治疗在下一代测序,向疗法和免疫疗法方面取得了重大进展.
- 有效的临床试验对于推进癌症研究,改善患者的治疗结果和开发个性化治疗至关重要.
- 篮子试验是一种现代,高效的临床试验设计,评估基于分子变化的多种癌症类型的治疗方法.
研究的目的:
- 审查癌症药物开发中的篮子试验的演变.
- 突出与篮子试验相关的潜在前景和当前障碍.
- 讨论关于导致FDA批准特定分子变化的篮子试验的显著例子.
主要方法:
- 篮子试验设计涉及对患者进行特定分子变化或生物标志物的查.
- 注册患者接受正在研究的向治疗.
- 统计考虑对于篮子试验的设计,分析和解释至关重要.
主要成果:
- 几个篮子试验已经导致美国食品和药物管理局 (FDA) 批准了不常见的分子变化.
- 例如,针对NTRK融合,BRAF突变和RET/FGFR1改变的试验.
- 讨论的值得注意的试验包括LOXO-TRK,VE-BASKET,ROAR Basket,LIBRETTO-001,ARROW,FIGHT-203,以及NCI-MoCha试验. 这些试验包括:
结论:
- 篮子试验有可能通过将重点从组织学转移到分子变化来彻底改变癌症治疗.
- 这种方法可以根据特定的生物标志物识别患者的有效疗法.
- 篮子试验为开发个性化癌症治疗提供了一个有希望的途径.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.5K
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
8.0K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K